Is Xvivo Perfusion AB publ stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Xvivo Perfusion AB publ pays dividends. Last time was Thursday 1st of January 1970 where the investors holding the stock on Tuesday 15th of March 2022 were paid SEK0.285 per share. Over the last 1 times between 2022 and 2022, Xvivo Perfusion AB publ has paid SEK0.285 with an average of SEK0.29 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Xvivo Perfusion AB publ 10 years ago, but if you had invested on Tuesday 10th of August 2021 when the price was SEK406.00, you would have made a profit of SEK41.72 per share or 10.28%
Yes, the average daily trading liquidity for Xvivo Perfusion AB publ is SEK9 843 thousand. You should therefore be able to get in and out of your positions relatively fast.
Xvivo Perfusion AB publ has no real debt, which is good in periods of high inflation. Xvivo Perfusion AB publ has a very good net profit margin of 27.21% and should have very high tolerances against inflation.
We have calculated the inflation risk for Xvivo Perfusion AB publ to be low [0.3 of 1]
US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.